Doctor profile · Federal record
Dr. Justin Clark, MD
Dermatology Physician (CMS: Dermatology) · Lubbock, TX
- NPI 1639164098
- Accepts Medicare
- MIPS 88.8 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3601 22Nd St, Lubbock Dermatology
Lubbock, TX 794101309
(806) 796-7193
fax (806) 796-0034
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- October 25, 2007
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Texas #K4662
- Medicaid
- TX #120680701
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1639164098. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
11,152
Distinct HCPCS
10
Medicare allowed
$753,354
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 4,957 | 842 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,510 | 1,191 | $86 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,309 | 1,043 | $54 | |
88331 |
Pathology examination of specimen during surgery, first tissue block | 470 | 335 | $98 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 366 | 314 | $122 | |
11102 |
Biopsy of related skin growth, first growth | 332 | 302 | $93 | |
17110 |
Destruction of skin growth, 1-14 growths | 288 | 264 | $107 | |
88305 |
Pathology examination of tissue using a microscope, intermediate complexity | 245 | 203 | $68 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 185 | 138 | $161 | |
17311 |
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 182 | 154 | $537 |
In context: peer comparison
Among 5 peers in Lubbock Dermatology Physician, average services per provider: 240. This provider delivers 46× the peer median.Open Payments
Industry payments received
All-time total
$875
Transactions
49
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 8 | $230.82 | |
| Abbvie INC. | 8 | $156.63 | |
| E.R. Squibb & Sons, L.L.C. | 16 | $148.39 | |
| Leo Pharma INC. | 3 | $81.07 | |
| Novartis Pharmaceuticals Corporation | 4 | $77.19 | |
| Janssen Biotech, INC. | 3 | $56.06 | |
| Genzyme Corporation | 2 | $29.13 | |
| ConvaTec INC. | 1 | $26.97 | |
| Incyte Corporation | 1 | $23.82 | |
| Regeneron Healthcare Solutions, INC. | 1 | $18.79 | |
| Genentech USA, INC. | 1 | $14.84 | |
| Mayne Pharma Commercial LLC | 1 | $11.63 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
971
Patients
561
Total drug cost
$199,602
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 285 | 164 | $3,128 |
| Fluocinonide | Generic | 211 | 131 | $10,896 |
| Mupirocin | Generic | 107 | 76 | $1,113 |
| Hydrocortisone | Generic | 77 | 56 | $468 |
| Metronidazole | Generic | 49 | 29 | $3,263 |
| Clobetasol Propionate | Generic | 48 | 32 | $4,119 |
| Doxycycline Hyclate | Generic | 41 | 31 | $649 |
| Betamethasone Diprop Augmented (Betamethasone/Propylene Glyc) | Brand | 32 | 11 | $802 |
| Humira(Cf) Pen (Adalimumab) | Brand | 25 | 0 | $166,392 |
| Desonide | Generic | 19 | 18 | $1,689 |
Hospital affiliations
Frequently asked questions
What is Dr. Justin Clark's medical specialty?
Dr. Justin Clark practices Dermatology Physician in Lubbock, TX.
Where does Dr. Justin Clark practice?
Dr. Justin Clark practices at 3601 22Nd St, Lubbock, TX 794101309. Office phone: 8067967193.
What is Dr. Justin Clark's NPI?
Dr. Justin Clark's National Provider Identifier (NPI) is 1639164098, issued by NPPES.
Does Dr. Justin Clark accept Medicare assignment?
Yes. Dr. Justin Clark accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Justin Clark commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.